Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network | Zendy

Sophie Langner-Lemercier | Zendy; Caroline Houillier | Zendy; Carole Soussain | Zendy; Hervé Ghesquières | Zendy; Olivier Chinot | Zendy; Luc Taillandier | Zendy; Pierre Soubeyran | Zendy; T. Lamy | Zendy; Franck Morschhauser | Zendy; Alexandra BenouaichAmiel | Zendy; Guido Ahle | Zendy; MariePierre MolesMoreau | Zendy; Cécile MoluçonChabrot | Zendy; Pascal Bourquard | Zendy; Ghandi Damaj | Zendy; Fabrice Jardin | Zendy; Delphine LarrieuCiron | Zendy; Emmanuel Gyan | Zendy; Rémy Gressin | Zendy; Arnaud Jaccard | Zendy; Sylvain Choquet | Zendy; Annie Brion | Zendy; Olivier Casasnovas | Zendy; Philippe Colin | Zendy; Oumédaly Reman | Zendy; Adrian Tempescul | Zendy; JeanPierre Marolleau | Zendy; Michel Fabbro | Zendy; Florian Naudet | Zendy; Khê HoangXuan | Zendy; Roch Houot | Zendy

Open Access

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network

Author(s) -

Sophie Langner-Lemercier,

Caroline Houillier,

Carole Soussain,

Hervé Ghesquières,

Olivier Chinot,

Luc Taillandier,

Pierre Soubeyran,

T. Lamy,

Franck Morschhauser,

Alexandra BenouaichAmiel,

Guido Ahle,

MariePierre MolesMoreau,

Cécile MoluçonChabrot,

Pascal Bourquard,

Ghandi Damaj,

Fabrice Jardin,

Delphine LarrieuCiron,

Emmanuel Gyan,

Rémy Gressin,

Arnaud Jaccard,

Sylvain Choquet,

Annie Brion,

Olivier Casasnovas,

Philippe Colin,

Oumédaly Reman,

Adrian Tempescul,

JeanPierre Marolleau,

Michel Fabbro,

Florian Naudet,

Khê HoangXuan,

Roch Houot

Publication year - 2016

Publication title -

neuro-oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.005

H-Index - 125

eISSN - 1523-5866

pISSN - 1522-8517

DOI - 10.1093/neuonc/now033

Subject(s) - medicine , salvage therapy , refractory (planetary science) , oncology , progression free survival , chemotherapy , surgery , physics , astrobiology

Treatment of relapsed/refractory (R/R) primary CNS lymphoma (PCNSL) is poorly defined, because randomized trials and large studies are lacking. The aim of this study was to analyze the characteristics, management, and outcome of R/R PCNSL patients after first-line therapy in a nationwide cohort.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research